Sex differences in the metabolism of (+)-S-145, a novel thromboxane A₂ receptor antagonist in rat

References

• Arimura A., Asanuma F., Kurosawa A., Harada M., Nagai H., Koda A. Antiasthmatic activity of a novel thromboxane A2 antagonist, S-1452, in guinea pig. International Archives of Allergy and Immunology 1992; 98: 239–246
   PubMed Web of Science ®Google Scholar
• Bradbury A., Powell M. G., Curtis C. G. The enhanced biliary secretion of a taurine conjugate in the rat after intraduodenal administration of high doses of fenoclozic acid. Xenobiotica 1981; 11: 665–674
   PubMed Web of Science ®Google Scholar
• Diczfalusy U. β-Oxidation of eicosanoids. Progress in Lipid Research 1994; 33: 403–428
   Google Scholar
• Hanasaki K., Nagasaki T., Arita H. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145. Biochemical Pharmacology 1989; 38: 2007–2017
   PubMed Web of Science ®Google Scholar
• Halpin A. R., Ulm H. E., Till E. A., Kari H. P., Vyas P. K., Hunninghake B. D., Duggan E. D. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog and human. Drug Metabolism and Disposition 1993; 21: 1003–1011
   PubMed Web of Science ®Google Scholar
• Hutt J. A., Caldwell J. Amino acid conjugation. Conjugation Reactions in Drug Metabolism, G. J. Mulder. Taylor & Francis, London 1992; 273–305
   Google Scholar
• Kolis J. S., Posta J. E., Williams H. T., Sasso J. G. Identification of Trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation. Drug Metabolism and Disposition 1986; 14: 465–470
   Google Scholar
• Lageweg W., Wanders J. A. R. Studies on the effect of fenoprofen on the activation and oxidation of long chain and very long chain fatty acids in hepatocytes and subcellular fractions from rat liver. Biochemical Pharmacology 1993; 46: 79–85
   Google Scholar
• Mizojiri K., Norikura R., Yoshimori T., Nakanishi M., Iwatani K., Terui Y., Kikuti J., Nakagawa Y. Identification of metabolites of a new thomboxane A2 receptor antagonist, S-1452, in rats. Xenobiotic Metabolism and Disposition 1993; 8: 67–81, in Japanese
   Google Scholar
• Nagasaki T., Watanabe F., Katsuyama Y., Hamada Y., Ohtani M., Narisada M. Synthesis of [14C]- and [3H]-labelled (+)-[1R-[1α,2α(Z),3β,4α]]-7-[3-[(phenylsulfonyl)amino]-bicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, ((+)-S-145) and its calcium salt (S-1452). Journal of Labelled Compounds and Radiopharmaceuticals 1992; 31: 23–38
   Google Scholar
• Nagatsuka S., Ueda K., Ninomiya S., Esumi Y. Application of bioimage analyzer on drug metabolism studies using thin layer chromatography (I): performance of the system coupled to an image analyzer. Xenobiotic Metabolism and Disposition 1993; 8: 1261–1271
   Google Scholar
• Norikura R., Tanaka H., Yoshimori T., Futaguchi S., Iwamoto Y, Mizojiri K. Studies on the metabolic fate of a new thromboxane A2 receptor antagonist, S-1452 (II): distribution and excretion after single and repeated oral administration to rats. Xenobiotic Metabolism and Disposition 1993b; 8: 97–105, in Japanese
   Google Scholar
• Norikura R., Yoshimori T., Murakami T., Nakanishi M., Mizojiri K. Studies on the metabolic fate of a new thromboxane A2 receptor antagonist, S-1452 (I): absorption, distribution, metabolism and excretion after single administration to rats. Xenobiotic Metabolism and Disposition 1993a; 8: 83–96, in Japanese
   Google Scholar
• Norikura R., Yoshimori T., Murakami T., Nakanishi M., Mizojiri K. Studies on the metabolic fate of a new thromboxane A2 receptor antagonist, S-1452 (IV): absorption, distribution, metabolism and excretion in dogs and monkeys. Xenobiotic Metabolism and Disposition 1993c; 8: 113–125, in Japanese
   Google Scholar
• Okamoto J., Hirai K., Kitagawa T., Matsubara T. Capillary gas chromatographic method for the determination of the thromboxane A2 receptor antagonist S-1452 and its metabolites in human plasma. Journal of Chromatography 1992a; 583: 45–52
   Google Scholar
• Okamoto J., Hirai E., Suzuki Y., Fujimoto K., Kitagawa T., Matsubara T. Capillary gas chromatographic method for the determination of the thromboxane A2 receptor antagonist S-1452 and its metabolites in human urine. Journal of Chromatography 1992b; 583: 53–62
   Google Scholar
• Peffer C. R., Abraham J. D., Zamaitis A. M., Wong K. L., Alvin D. J. 3,4-Dichlorobenzyloxyacetic acid is extensively metabolized to a taurine conjugate in rats. Drug Metabolism and Disposition 1987; 15: 305–311
   PubMedGoogle Scholar
• Roberts J. B., Knights M. K. Inhibition of rat peroxisomal palmitoyl-CoA ligase by xenobiotic carboxylic acids. Biochemical Pharmacology 1992; 44: 261–267
   PubMed Web of Science ®Google Scholar
• Skett P. Hormonal regulation and sex differences of xenobiotic metabolism. Progress in Drug Metabolism 1987; 10: 85–140
   Google Scholar
• Suzuki H., Mori K., Yamada J., Suga T. Contribution of peroxisomal β-oxidation system to the chain-shortening of N-(α-methylbenzyl) azelaamic acid in rat liver. Biochemical Pharmacology 1990; 39: 1975–1981
   PubMedGoogle Scholar
• Tanaka Y., Deuti Y., Ishii I., Terai T. Sex differences in excretion of zenarestat in rat. Xenobiotica 1991a; 21: 1119–1125
   PubMed Web of Science ®Google Scholar
• Tanaka Y., Kadoh Y., Mukumoto S., Ishikawa H. The role of age and sex hormones on the urinary excretion of zenarestat in rats. Xenobiotica 1991b; 21: 1273–1279
   PubMed Web of Science ®Google Scholar
• Tohkin M., Yoshimatsu N., Matsubara T. Comparison of the action of epinephirine and a respiratory chain uncoupler, 2,4-dinitrophenol, on Ca2+ mobilization in isolated hepatocytes and perfused livers. Japanese Journal of Pharmacology 1988; 46: 61–69
   Google Scholar
• Watanabe F., Matsuura T., Shirahase K., Ohtani M. Synthesis of metabolites of S-1452 an orally active thromboxane A2 receptor antagonist. Chemical and Pharmaceutical Bulletin 1991; 39: 2842–2848
   PubMedGoogle Scholar
• Yamada J., Ogawa S., Horie S., Watanabe T., Suga T. Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial β-oxidation of ω-phenyl fatty acids in rat liver. Biochimica et Biophysica Acta 1987; 921: 292–301
   PubMedGoogle Scholar
• Yamaguchi Y., Baba T., Touchi A., Matsubara T. In vitro studies to elucidate the metabolic pathway of (+)-S-145, a thromboxane A2 receptor antagonist, in rats. Drug Metabolism and Disposition 1995; 23: 1195–1201
   Google Scholar
• Yoshida Y., Yamada J., Watanabe T., Suga T., Takayama H. Participation of the peroxisomal β-oxidation system in the chain-shortening of PCA16, a metabolite of the cytosine arabinoside prodrug, YNK01, in rat liver. Biochemical Pharmacology 1990; 39: 1505–1512
   PubMed Web of Science ®Google Scholar